| Year |
Citation |
Score |
| 2023 |
Wang R, Song S, Qin J, Yoshimura K, Peng F, Chu Y, Li Y, Fan Y, Jin J, Dang M, Dai E, Pei G, Han G, Hao D, Li Y, ... ... Hanash SM, et al. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell. PMID 37419119 DOI: 10.1016/j.ccell.2023.06.005 |
0.343 |
|
| 2023 |
Liu S, Xie SM, Liu W, Gagea M, Hanker AB, Nguyen N, Raghavendra AS, Yang-Kolodji G, Chu F, Neelapu SS, Hanash S, Zimmermann J, Arteaga CL, Tripathy D. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Research Square. PMID 36824840 DOI: 10.21203/rs.3.rs-2388864/v1 |
0.362 |
|
| 2023 |
León-Letelier RA, Abdel Sater AH, Chen Y, Park S, Wu R, Irajizad E, Dennison JB, Katayama H, Vykoukal JV, Hanash S, Ostrin EJ, Fahrmann JF. Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis. Cancers. 15. PMID 36765792 DOI: 10.3390/cancers15030834 |
0.345 |
|
| 2021 |
Kato T, Vykoukal JV, Fahrmann JF, Hanash S. Extracellular Vesicles in Lung Cancer: Prospects for Diagnostic and Therapeutic Applications. Cancers. 13. PMID 34572829 DOI: 10.3390/cancers13184604 |
0.305 |
|
| 2021 |
Zhu M, Peng R, Liang X, Lan Z, Tang M, Hou P, Song JH, Mak CSL, Park J, Zheng SE, Huang A, Ma X, Chen R, Chang Q, Logothetis CJ, ... ... Hanash S, et al. P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis. Oncogene. PMID 34471235 DOI: 10.1038/s41388-021-02000-3 |
0.345 |
|
| 2021 |
Bommi PV, Bowen CM, Reyes-Uribe L, Wu W, Katayama H, Rocha P, Parra ER, Francisco-Cruz A, Ozcan Z, Tosti E, Willis JA, Wu H, Taggart MW, Burks JK, Lynch PM, ... ... Hanash SM, et al. The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells. Cancer Research. 81: 2760-2773. PMID 34003775 DOI: 10.1158/0008-5472.CAN-20-2896 |
0.309 |
|
| 2021 |
Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, Zhao M, Tatlonghari G, Zhang S, Hao D, Lu Y, Zhao S, Badgwell BD, Blum Murphy M, Shanbhag N, ... ... Hanash S, et al. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nature Medicine. PMID 33398161 DOI: 10.1038/s41591-020-1125-8 |
0.336 |
|
| 2020 |
Subbalakshmi AR, Kundnani D, Biswas K, Ghosh A, Hanash SM, Tripathi SC, Jolly MK. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype. Frontiers in Oncology. 10: 553342. PMID 33014880 DOI: 10.3389/fonc.2020.553342 |
0.674 |
|
| 2019 |
Bocci F, Tripathi SC, Vilchez Mercedes SA, George JT, Casabar JP, Wong PK, Hanash SM, Levine H, Onuchic JN, Jolly MK. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype. Integrative Biology : Quantitative Biosciences From Nano to Macro. PMID 31329868 DOI: 10.1093/Intbio/Zyz021 |
0.719 |
|
| 2019 |
Yao W, Rose JL, Wang W, Seth S, Jiang H, Taguchi A, Liu J, Yan L, Kapoor A, Hou P, Chen Z, Wang Q, Nezi L, Xu Z, Yao J, ... ... Hanash S, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. PMID 30918400 DOI: 10.1038/S41586-019-1062-1 |
0.313 |
|
| 2018 |
Jolly MK, Preca BT, Tripathi SC, Jia D, George JT, Hanash SM, Brabletz T, Stemmler MP, Maurer J, Levine H. Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer. Apl Bioengineering. 2: 031908. PMID 31069317 DOI: 10.1063/1.5024874 |
0.705 |
|
| 2018 |
Jia D, George J, Tripathi S, Kundnani D, Lu M, Hanash S, Onuchic J, Jolly MK, Levine H. Testing the gene expression classification of the EMT spectrum. Physical Biology. PMID 30557866 DOI: 10.1088/1478-3975/Aaf8D4 |
0.675 |
|
| 2018 |
Jolly MK, Somarelli JA, Sheth M, Biddle A, Tripathi SC, Armstrong AJ, Hanash SM, Bapat SA, Rangarajan A, Levine H. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas. Pharmacology & Therapeutics. PMID 30268772 DOI: 10.1016/J.Pharmthera.2018.09.007 |
0.717 |
|
| 2017 |
Jia D, Jolly MK, Tripathi SC, Den Hollander P, Huang B, Lu M, Celiktas M, Ramirez-Peña E, Ben-Jacob E, Onuchic JN, Hanash SM, Mani SA, Levine H. Distinguishing mechanisms underlying EMT tristability. Cancer Convergence. 1: 2. PMID 29623961 DOI: 10.1186/s41236-017-0005-8 |
0.654 |
|
| 2017 |
Bocci F, Jolly MK, Tripathi SC, Aguilar M, Hanash SM, Levine H, Onuchic JN. Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling. Journal of the Royal Society, Interface. 14. PMID 29187638 DOI: 10.1098/Rsif.2017.0512 |
0.705 |
|
| 2017 |
Tripathi SC, Fahrmann JF, Celiktas M, Aguilar M, Marini KD, Jolly MK, Katayama H, Wang H, Murage EN, Dennison JB, Watkins DN, Levine H, Ostrin EJ, Taguchi A, Hanash SM. MCAM mediates chemoresistance in small cell lung cancer via the PI3K/AKT/SOX2 signaling pathway. Cancer Research. PMID 28646020 DOI: 10.1158/0008-5472.CAN-16-2874 |
0.633 |
|
| 2017 |
Jolly MK, Tripathi SC, Somarelli JA, Hanash SM, Levine H. Epithelial-mesenchymal plasticity: How have quantitative mathematical models helped improve our understanding? Molecular Oncology. PMID 28548388 DOI: 10.1002/1878-0261.12084 |
0.65 |
|
| 2017 |
Kerros C, Tripathi SC, Zha D, Mehrens JM, Sergeeva A, Philips AV, Qiao N, Peters HL, Katayama H, Sukhumalchandra P, Ruisaard KE, Perakis AA, St John LS, Lu S, Mittendorf EA, ... ... Hanash SM, et al. Neuropilin-1 mediates Neutrophil Elastase uptake and cross-presentation in breast cancer cells. The Journal of Biological Chemistry. PMID 28468826 DOI: 10.1074/Jbc.M116.773051 |
0.304 |
|
| 2017 |
Peters HL, Tripathi SC, Kerros C, Katayama H, Garber HR, St John LS, Federico L, Meraz IM, Roth JA, Sepesi B, Majidi M, Ruisaard K, Clise-Dwyer K, Roszik J, Gibbons DL, ... ... Hanash SM, et al. Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells. Cancer Immunology Research. PMID 28254787 DOI: 10.1158/2326-6066.Cir-16-0141 |
0.305 |
|
| 2016 |
Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E, Levine H. Stability of the hybrid epithelial/mesenchymal phenotype. Oncotarget. PMID 27008704 DOI: 10.18632/Oncotarget.8166 |
0.721 |
|
| 2016 |
Tripathi SC, Peters HL, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez-Canales J, Liu H, Behrens C, Wistuba II, Ben-Jacob E, Levine H, Molldrem JJ, ... Hanash SM, et al. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proceedings of the National Academy of Sciences of the United States of America. PMID 26929325 DOI: 10.1073/Pnas.1521812113 |
0.617 |
|
| 2016 |
Lim SO, Li CW, Xia W, Lee HH, Chang SS, Shen J, Hsu JL, Raftery D, Djukovic D, Gu H, Chang WC, Wang HL, Chen ML, Huo L, Chen CH, ... ... Hanash SM, et al. EGFR signaling enhances aerobic glycolysis in triple negative breast cancer cells to promote tumor growth and immune escape. Cancer Research. PMID 26759242 DOI: 10.1158/0008-5472.Can-15-2478 |
0.324 |
|
| 2015 |
Pankoval D, Chen Y, Terajima M, Schliekelman MJ, Baird BN, Fahrenholtz M, Sun L, Gill BJ, Vadakkan TJ, Kim MP, Ahn YH, Roybal JD, Liu X, Parra Cuentas ER, Rodriguez J, ... ... Hanash SM, et al. Cancer-associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma. Molecular Cancer Research : McR. PMID 26631572 DOI: 10.1158/1541-7786.Mcr-15-0307 |
0.319 |
|
| 2015 |
Schliekelman MJ, Taguchi A, Zhu J, Dai X, Rodriguez J, Celiktas M, Zhang Q, Chin A, Wong CH, Wang H, McFerrin L, Selamat SA, Yang C, Kroh EM, Garg KS, ... ... Hanash SM, et al. Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. Cancer Research. 75: 1789-800. PMID 25744723 DOI: 10.1158/0008-5472.Can-14-2535 |
0.427 |
|
| 2014 |
Lu M, Huang B, Hanash SM, Onuchic JN, Ben-Jacob E. Modeling putative therapeutic implications of exosome exchange between tumor and immune cells. Proceedings of the National Academy of Sciences of the United States of America. 111: E4165-74. PMID 25246552 DOI: 10.1073/Pnas.1416745111 |
0.308 |
|
| 2013 |
Zhang S, Mercado-Uribe I, Hanash S, Liu J. iTRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development. Plos One. 8: e80120. PMID 24348907 DOI: 10.1371/journal.pone.0080120 |
0.379 |
|
| 2013 |
Baird BN, Schliekelman MJ, Ahn YH, Chen Y, Roybal JD, Gill BJ, Mishra DK, Erez B, O'Reilly M, Yang Y, Patel M, Liu X, Thilaganathan N, Larina IV, Dickinson ME, ... ... Hanash SM, et al. Fibulin-2 is a driver of malignant progression in lung adenocarcinoma. Plos One. 8: e67054. PMID 23785517 DOI: 10.1371/Journal.Pone.0067054 |
0.31 |
|
| 2011 |
Zhang Q, Taguchi A, Schliekelman M, Wong CH, Chin A, Kuick R, Misek DE, Hanash S. Comprehensive proteomic profiling of aldehyde dehydrogenases in lung adenocarcinoma cell lines. International Journal of Proteomics. 2011: 145010. PMID 22110949 DOI: 10.1155/2011/145010 |
0.314 |
|
| 2011 |
Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Research. 71: 7670-82. PMID 21987723 DOI: 10.1158/0008-5472.Can-11-0964 |
0.364 |
|
| 2008 |
Faça VM, Ventura AP, Fitzgibbon MP, Pereira-Faça SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC, Drescher CW, Schummer M, McIntosh MW, Knudsen BS, Hanash SM. Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. Plos One. 3: e2425. PMID 18560578 DOI: 10.1371/Journal.Pone.0002425 |
0.33 |
|
| 2005 |
Creighton CJ, Bromberg-White JL, Misek DE, Monsma DJ, Brichory F, Kuick R, Giordano TJ, Gao W, Omenn GS, Webb CP, Hanash SM. Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation. Molecular Cancer Research : McR. 3: 119-29. PMID 15798092 DOI: 10.1158/1541-7786.Mcr-04-0189 |
0.342 |
|
| 2003 |
Creighton C, Kuick R, Misek DE, Rickman DS, Brichory FM, Rouillard JM, Omenn GS, Hanash S. Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice. Genome Biology. 4: R46. PMID 12844362 DOI: 10.1186/Gb-2003-4-7-R46 |
0.346 |
|
| 2002 |
Misek DE, Chang CL, Kuick R, Hinderer R, Giordano TJ, Beer DG, Hanash SM. Transforming properties of a Q18-->E mutation of the microtubule regulator Op18. Cancer Cell. 2: 217-28. PMID 12242154 DOI: 10.1016/S1535-6108(02)00124-1 |
0.393 |
|
| 2002 |
Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Research. 62: 4722-9. PMID 12183431 |
0.302 |
|
| Show low-probability matches. |